Trials / Not Yet Recruiting
Not Yet RecruitingNCT07486115
A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People
A Phase 1, Randomised, Single-blind, Placebo-controlled Trial to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BI 3814916 in Healthy Male and Female Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | BI 3814916 | BI 3814916 |
| DRUG | Placebo matching BI 3814916 | Placebo matching BI 3814916 |
Timeline
- Start date
- 2026-05-18
- Primary completion
- 2027-07-12
- Completion
- 2027-07-12
- First posted
- 2026-03-20
- Last updated
- 2026-04-02
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07486115. Inclusion in this directory is not an endorsement.